View Clinical Trial (Medical Research Study)
Extension Study Of Tanezumab In Osteoarthritis - NCT00809783-04210(Clinical Trial 260065)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Auburn |
|
State:
|
|
ME |
| Zip Code: |
|
04210 |
| Conditions: |
|
Osteoarthritis |
| Purpose: |
|
Safety extension study of Phase 3 Osteoarthritis trials with Tanezumab
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Must have participated in previous (specific) Phase 3 trials of Tanezumab in
osteoarthritis
Exclusion Criteria:
- Willing to comply with scheduled visits and treatment plan Is medically fit to
participate in the trial in the judgement of the Investigator |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|